ACTU
Actuate Therapeutics Inc$0.34-0.03 (-8.71%)Prev Close$0.37·MCap$9.6M·P/E—·Vol469.9K·Yield—
▲
Buys (12M)
1
$81.7K
▼
Sells (12M)
2
$2.15M
◆
Net Activity
Net Seller
$2.07M
●
Active Insiders
3
last 12 mo
Over the past 12 months, insider activity at Actuate Therapeutics Inc (ACTU) has been dominated by selling, with 1 insider purchase totaling $81.7K and 2 insider sales totaling $2.15M. The most recent insider transaction was by SCHMITT DANIEL M (director, officer: President, CEO and Director), who purchased $81.7K worth of shares on Oct 29, 2026. Actuate Therapeutics Inc operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $9.6M.
ACTU Insider Trading Activity
ACTU Insider Buying Activity
The following table shows recent insider purchases of Actuate Therapeutics Inc (ACTU) stock reported via SEC Form 4 filings.
ACTU Insider Selling Activity
The following table shows recent insider sales of Actuate Therapeutics Inc (ACTU) stock reported via SEC Form 4 filings.